Affiliation:
1. Laboratoire de Bactériologie,1 and
2. Setor de Bacteriologia, Laboratório Lâmina LTDA, 71-Botafogo, Rio de Janeiro, RJ, Brazil 22280-0302
3. Laboratoire de Biochimie,3 Faculté de Médecine, 63001 Clermont-Ferrand Cedex, and
4. CNRS-UBO-MNHN, FRE 2125, 29000 Quimper,4 France, and
Abstract
ABSTRACT
Serratia marcescens
Rio-5, one of 18 extended-spectrum β-lactamase (ESBL)-producing strains isolated in several hospitals in Rio de Janeiro (Brazil) in 1996 and 1997, exhibited a high level of resistance to aztreonam (MIC, 512 μg/ml) and a distinctly higher level of resistance to cefotaxime (MIC, 64 μg/ml) than to ceftazidime (MIC, 8 μg/ml). The strain produced a plasmid-encoded ESBL with a pI of 7.5 whose
bla
gene was not related to those of other plasmid-mediated Ambler class A ESBLs. Cloning and sequencing revealed a
bla
gene encoding a novel class A β-lactamase in functional group 2be, designated BES-1 (Brazil extended-spectrum β-lactamase). This enzyme had 51% identity with chromosomal class A penicillinase of
Yersinia enterocolitica
Y56, which was the most closely related enzyme and 47 to 48% identity with CTX-M-type β-lactamases, which were the most closely related ESBLs. In common with CTX-M enzymes, BES-1 exhibited high cefotaxime-hydrolyzing activity (
k
cat
, 425 s
−1
). However, BES-1 differed from CTX-M enzymes by its significant ceftazidime-hydrolyzing activity (
k
cat
, 25 s
−1
), high affinity for aztreonam (
K
i
, 1 μM), and lower susceptibility to tazobactam (50% inhibitory concentration [IC
50
], 0.820 μM) than to clavulanate (IC
50
, 0.045 μM). Likewise, certain characteristic structural features of CTX-M enzymes, such as Phe-160, Ser-237, and Arg-276, were observed for BES-1, which, in addition, harbored different residues (Ala-104, Ser-171, Arg-220, Gly-240) and six additional residues at the end of the sequence. BES-1, therefore, may be an interesting model for further investigations of the structure-function relationships of class A ESBLs.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology